NCT04386252: A trial that was reported late by Aivita Biomedical, Inc.
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT04386252 |
|---|---|
| Title | Adaptive Phase I-II Clinical Trial of Preventive Vaccine Consisting of Autologous Dendritic Cells Previously Incubated With S-protein From Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2), in Subjects Negative for COVID-19 Infection and Anti-SARS-CoV-2 Antibodies |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Jan. 31, 2023 |
| Completion date | June 30, 2023 |
| Required reporting date | June 29, 2024, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | May 4, 2023 |
| Days late | None |